These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11849209)

  • 1. Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients.
    Karlsson K; Strömberg M; Liliemark J; Delannoy A; Johnson SA; Porwit A; Kimby E; Lärfars G; Cristiansen I; Nilsson G; Celsing F; Sundström G; Luthman M; Tidefelt U; Wallvik J; Juliusson G
    Br J Haematol; 2002 Mar; 116(3):538-48. PubMed ID: 11849209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia.
    Juliusson G; Christiansen I; Hansen MM; Johnson S; Kimby E; Elmhorn-Rosenborg A; Liliemark J
    J Clin Oncol; 1996 Jul; 14(7):2160-6. PubMed ID: 8683250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
    Byrd JC; Peterson B; Piro L; Saven A; Vardiman JW; Larson RA; Schiffer C
    Leukemia; 2003 Feb; 17(2):323-7. PubMed ID: 12592330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia.
    Juliusson G; Liliemark J
    Ann Oncol; 1996 Apr; 7(4):373-9. PubMed ID: 8805929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia.
    Robak T; Błoński JZ; Kasznicki M; Góra-Tybor J; Dwilewicz-Trojaczek J; Stella-Hołowiecka B; Wołowiec D
    Hematol J; 2002; 3(5):244-50. PubMed ID: 12391542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia.
    Tefferi A; Levitt R; Li CY; Schroeder G; Tschetter LK; Michalak JC; Krook JE; Witzig TE
    Am J Clin Oncol; 1999 Oct; 22(5):509-16. PubMed ID: 10521069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
    Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G;
    Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK).
    Betticher DC; Ratschiller D; Hsu Schmitz SF; von Rohr A; Hess U; Zulian G; Wernli M; Tichelli A; Tobler A; Fey MF; Cerny T
    Ann Oncol; 1998 Jul; 9(7):721-6. PubMed ID: 9739437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
    Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F
    Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
    Robak T; Błasinka-Morawiec M; Krykowski E; Kasznicki M; Płuzanska A; Potemski P; Hellmann A; Zaucha JM; Lewandowski K; Dmoszynska A; Hansz J; Komarnicki M; Konopka L; Durzynski T; Ceglarek B; Sikorska A; Kotlarek-Haus S; Mazur G; Urasinski I; Zdziarska B; Maj S; Kopec I; Skotnicki AB; Dwilewicz-Trojaczek J; Grieb P
    Leuk Lymphoma; 1996 Aug; 22(5-6):509-14. PubMed ID: 8882965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Chlorodeoxyadenosine treatment in non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience. International Society for Chemo-Immunotherapy.
    Brugiatelli M; Holowiecka B; Dmoszynska A; Krieger O; Planinc-Peraica A; Labar B; Callea V; Morabito F; Jaksic B; Holowiecki J; Lutz D
    Ann Hematol; 1996 Aug; 73(2):79-84. PubMed ID: 8774616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group.
    Robak T; Blonski JZ; Wawrzyniak E; Gora-Tybor J; Palacz A; Dmoszynska A; Konopka L; Warzocha K; Jamroziak K
    Cancer; 2009 Jan; 115(1):94-100. PubMed ID: 19025975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment.
    Robak T; Boński JZ; Kasznicki M; Góra-Tybor J; Hellmann A; Konopka L; Dmoszyńska A; Dwilewicz-Trojaczek J; Wołowiec D;
    Eur J Haematol; 2002 Jul; 69(1):27-36. PubMed ID: 12270059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia.
    Robak T; Błasińska-Morawiec M; Błoński JZ; Dmoszyńska A
    Leuk Lymphoma; 1999 Jun; 34(1-2):151-7. PubMed ID: 10350343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients.
    Robak T; Bloński JZ; Kasznicki M; Konopka L; Ceglarek B; Dmoszyńska A; Soroka-Wojtaszko M; Skotnicki AB; Nowak W; Dwilewicz-Trojaczek J; Tomaszewska A; Hellmann A; Lewandowski K; Kuliczkowski K; Potoczek S; Zdziarska B; Hansz J; Kroll R; Komarnicki M; Holowiecki J; Grieb P
    Br J Haematol; 2000 Feb; 108(2):357-68. PubMed ID: 10691866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas.
    Laurencet F; Ballabeni P; Rufener B; Hess U; Cerny T; Fey M; Luthi JM; Plancherel C; Zulian GB;
    Acta Haematol; 2007; 117(1):40-7. PubMed ID: 17095858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia.
    Tefferi A; Li CY; Reeder CB; Geyer SM; Allmer C; Levitt R; Michalak JC; Addo F; Krook JE; Witzig TE; Schaefer PL; Mailliard JA
    Leukemia; 2001 Aug; 15(8):1171-5. PubMed ID: 11480558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL).
    Delannoy A; Martiat P; Gala JL; Deneys V; Ferrant A; Bosly A; Schieff JM; Michaux JL
    Leukemia; 1995 Jul; 9(7):1130-5. PubMed ID: 7630184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia.
    Tallman MS; Hakimian D; Zanzig C; Hogan DK; Rademaker A; Rose E; Variakojis D
    J Clin Oncol; 1995 Apr; 13(4):983-8. PubMed ID: 7707127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Litchy S; Barton JH; Houston GA; Hermann RC; Bradof JE; Greco FA;
    J Clin Oncol; 2003 May; 21(9):1746-51. PubMed ID: 12721250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.